HIV Redirecting Innate Immunity by Vpu Targeting of JAK1
HIV Redirecting Innate Immunity by Vpu Targeting of JAK1
批准号:
10619889
负责人:
DAVID JESSE SANCHEZ
金额:
$7.15万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-20 至 2025-05-31
关键词:
Amino Acid MotifsBiochemicalCD4 Positive T LymphocytesCell physiologyCellsCellular ImmunityCellular biologyCytokine ReceptorsCytokine SignalingDataDendritic CellsDetectionGenesGoalsHIVHIV InfectionsImmune responseImmune systemImmunityInfectionInnate Immune ResponseInnate Immune SystemInterferon Type IInterferon Type IIInterferonsJAK1 geneLinkLysosomesMapsMediatingMethodsMutation AnalysisNamesNatural ImmunityOutcomePathogenesisPatientsPersonsPhenotypePhosphorylationProductionProteinsRefractoryResearch Project GrantsSTAT1 geneSerumSignal TransductionSystemT-LymphocyteTechniquesTertiary Protein StructureUbiquitinationViralVirusVirus DiseasesVirus ReplicationWorkadaptive immunityantiviral immunityarmcellular targetingcytokinedomain mappingexperienceimmune clearanceinsightmulticatalytic endopeptidase complexresponsetumor-immune system interactionsvpu Protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
It is well known that the pathogenesis of HIV is intricately linked to the immune system. For HIV to promote its
replication and long-term infection HIV must also modulate cytokine signaling to manipulate the immune
microenvironment HIV is existing in. In our previous work we have found that HIV has encoded accessory
genes that are able to block the action of the important innate antiviral cytokine named Type I Interferon. Type
I Interferons were named for their ability to interfere with the replication of viruses and HIV has encoded
multiple ways to block this cytokine. The overall goal of this R03 application is to determine how one of the
HIV-encoded genes that blocks Type I Interferon can block this signaling in T cells, the major cell infected by
HIV. Long term, this work is critical to set the stage to better understand how HIV sustains itself in a person
and avoids elimination by the innate immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disruption of Type I Interferon Induction by a KSHV Homologue of IPS-1
-
批准号:10258718
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2021
-
负责人:DAVID JESSE SANCHEZ
-
依托单位:
KSHV Modulation of Type I Interferon
-
批准号:8542335
-
项目类别:
-
资助金额:$10.95万
-
财政年份:2013
-
负责人:DAVID JESSE SANCHEZ
-
依托单位:
KSHV Modulation of Type I Interferon
-
批准号:8662232
-
项目类别:
-
资助金额:$10.95万
-
财政年份:2013
-
负责人:DAVID JESSE SANCHEZ
-
依托单位:
海外基金